We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Unreliable Microarray Probes Hamper Research

By Biotechdaily staff writers
Posted on 14 Sep 2004
Molecular biologists who were concerned about the poor reproducibility of results in their field evaluated commercially available microarray biochips and found that greater than 19% of the probes on each platform did not correspond to their appropriate mRNA reference sequence (RefSeq)

The Reference Sequence (RefSeq) database provides a biologically nonredundant collection of DNA, RNA, and protein sequences. More...
Each RefSeq represents a single, naturally occurring molecule from a particular organism. RefSeq standards serve as the basis for medical, functional, and diversity studies; they provide a stable reference for gene identification and characterization, mutation analysis, expression studies, polymorphism discovery, and comparative analyses.

RefSeqs are frequently based on the records of GenBank (NCBI, U.S. National Center for Biotechnology Information) but differ in that each RefSeq is a synthesis of information, not a piece of a primary research data in itself. Similar to a review article in the literature, a RefSeq is an interpretation by a particular group at a particular time. RefSeqs can be retrieved in several different ways: by searching the Entrez Nucleotide or Protein database, by BLAST (basic local alignment search tool) searching, by FTP (file transfer protocol), or through links from other NCBI resources.

Investigators at Harvard Medical School (Boston, MA, USA) and Washington University (St. Louis, MO, USA) inspected commercially available microarray biochips in order to assess the accuracy of individual probe sequences used to query gene expression. They reported in the August 2004 issue of Physiological Genomics that more than 19% of the probe sequences failed to perfectly correspond with the appropriate mRNA as defined by the reference sequence. Furthermore, and not surprisingly, they found that sequence-verified probes performed more consistently, and with higher accuracy, within replicates and across different versions of the technology.




Related Links:
National Center for Biotechnology Information
Harvard University
Washington University

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Aspiration System
VACUSAFE
New
Hematology Consumables
Bioblood Devices
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.